A new bipartisan bill could end the import of primates for U.S. research, targeting the roughly 20,000 monkeys brought into the country each year for laboratories or their suppliers.
Sponsored by U.S. Reps. Greg Steube, R-Fla., and Dina Titus, D-Nev., the Preventing Risky Importation of Monkeys to Avoid Toxic Exposures (PRIMATE) Act (H.R. 8471) aims to reduce the risk of introducing dangerous path...
The PRIMATE Act represents a convergence of biosecurity concerns, ethical advocacy, and scientific evolution. At its core, the bill frames primate imports as a public health risk, leveraging recent pathogen exposure incidents to justify restrictive measures. This narrative aligns with PETA’s long-standing opposition to animal research, which now finds bipartisan legislative traction. The FDA’s parallel shift toward NAMs lends credibility to the argument that animal testing is becoming obsolete, ...